Kezar Life Sciences Inc (KZR)
0.7633
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.7633
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Accounts Payable (Quarterly): 5.059M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.059M |
December 31, 2023 | 8.251M |
September 30, 2023 | 3.12M |
June 30, 2023 | 2.492M |
March 31, 2023 | 4.136M |
December 31, 2022 | 2.479M |
September 30, 2022 | 2.274M |
June 30, 2022 | 1.922M |
March 31, 2022 | 1.359M |
December 31, 2021 | 2.028M |
September 30, 2021 | 1.543M |
June 30, 2021 | 1.633M |
March 31, 2021 | 3.578M |
Date | Value |
---|---|
December 31, 2020 | 2.358M |
September 30, 2020 | 1.285M |
June 30, 2020 | 1.007M |
March 31, 2020 | 1.583M |
December 31, 2019 | 0.823M |
September 30, 2019 | 0.824M |
June 30, 2019 | 0.955M |
March 31, 2019 | 1.448M |
December 31, 2018 | 0.193M |
September 30, 2018 | 0.662M |
June 30, 2018 | 1.105M |
March 31, 2018 | 0.717M |
December 31, 2017 | 0.547M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.823M
Minimum
Dec 2019
8.251M
Maximum
Dec 2023
2.435M
Average
1.975M
Median
Accounts Payable (Quarterly) Benchmarks
Accuray Inc | 44.43M |
Tonix Pharmaceuticals Holding Corp | 6.649M |
Acumen Pharmaceuticals Inc | 3.079M |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |